During the past decade, Dr. Judy van Stralen conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dr. Judy van Stralen" #1 collaborator was "Purdue Pharma LP" with 2 trials as a collaborator and "Purdue Pharma, Canada" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Dr. Judy van Stralen" are "ADHD" (3 trials). Many other conditions were trialed in "Dr. Judy van Stralen" in a lesser frequency.

Most popular intervention types in "Dr. Judy van Stralen" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "PRC-063 25 mg" (2 trials), "PRC-063 45 mg" (2 trials), "PRC-063 70 mg" (2 trials), "Placebo" (2 trials) and "Drug: PRC-063" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dr. Judy van Stralen" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Dr. Judy van Stralen". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Dr. Judy van Stralen, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Dr. Judy van Stralen, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".